Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.00 (0.00%)
Bid:
2.10
Ask:
2.30
Spread: 0.20 (9.524%)
Market Cap: £3.01m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Board Appointment and Pre-Close Trading Update

24 Oct 2018 07:00

RNS Number : 9542E
Image Scan Holdings PLC
24 October 2018
 

24 October 2018

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

IMAGE SCAN HOLDINGS PLC

 

("Image Scan" or the "Company")

 

 

Board Appointment and Pre-Close Trading Update

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets provides a pre-close trading update ahead of its results for the year ended 30 September 2018 and announces the appointment of Sarah Atwell-King to the board.

 

Key Points:

 

· Sales of £3.5m (2017: £5.0m) at a gross margin of 48% (2017: 39%)

· Unaudited trading profit before exceptional expenditure and tax of approximately £45k (2017: £480k)

· Exceptional costs of approximately £245k against the aborted acquisition of Todd Research Limited led to a loss for the year of £200k

· £1.0m order for portable X-ray systems was cancelled, with the Company's agreement, in January 2018. The units were re-sold

· Record number of industrial systems were delivered including to customers in the Eastern Europe and Asia

· A new research and development programme to create a new range of security X-ray systems alongside the current portable range will be started in FY 2019

· An internal restructuring has started with Sarah Atwell-King joining the board as Financial Director and the appointments of a new head of operations and sales manager

· £780k of cash at the end of the period (2017: £1.2m)

 

 

After a strong FY 2017, the Company, as previously announced, suffered two setbacks during FY 2018. The first of these was the cancellation of a large order from an important Asian customer in February; the second was the failure to garner support from the Company's largest shareholder for the intended acquisition of security X-ray company Todd Research Limited. The first of these contributed to adverse sales performance, the second added £245k of exceptional costs. The impact of these setbacks was partially offset by strong performance in the industrial area, where the company provides X-ray machines for inspection of catalytic converters in the manufacturing process. A record number of these machines were delivered as major customers continued with the role out of X-ray inspection into their global manufacturing operations.

 

Sales declined to £3.5m (2017: £5.0m), impacted both by the cancelled order and lower security system sales in the Indian subcontinent. Gross margins were strong at 48% (2017: 39%) reflecting the change in the sales mix. Overheads (excluding the transaction costs relating to the failed acquisition of Todd Research Limited) were fractionally higher at £1.6m (2017: £1.5m) and included a planned £100k increase in Research and Development spend. Subject to any audit adjustments, profit before tax and exceptional costs was approximately £45k (2017: £480k).

 

The acquisition of Todd Research Limited had been a part of the Company's strategy for some time prior to FY 2018. It was disappointing that, despite extensive face to face communication with Rise Step International Development Limited, the Company's largest shareholder, in the latter stages of the process, we were unable to achieve a positive vote for the resolutions required to complete the acquisition. A further extended face to face meeting was held after the adjournment on the General Meeting, but Rise Step, while supporting the overall strategy, remained opposed to the issuing of shares at the price achieved in the fund raising. Legal and other costs totaling approximately £245k had been occurred leading to a pre-tax loss, after exceptional expenditure of approximately £200k.

 

The year ended with a positive cash balance of £780k (2017: £1.2m).

 

The Company's stock includes portable systems in Work in Progress, manufactured in anticipation of new orders. This will allow a rapid response as they are received early in the new financial year.

 

In order to return the company to the growth path seen from FY 2015 to FY 2017 a number of changes will be made: Sarah Atwell-King, previously Financial Controller, will join the board as Financial Director, retaining her Company Secretary role. Sarah brings considerable organisational and management strength to the board.

 

A new operations manager is expected to join the Company in November who will focus on manufacturing quality and new product development; the European sales manager is being replaced with the incoming person focusing on sales growth in both Europe (including the UK) and South America. The Company's product strategy is evolving and a product development programme is to be launched that will add a new range of security X-ray systems serving a different customer group from the current portable scanners.

 

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Sarah Ann Atwell-King, aged 50 years, has been a director of the following companies during the five years preceding the date of this announcement:

 

Current directorships

Past directorships

Nil

Nil

 

 

Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

Sarah is the beneficial owner of 75,000 ordinary shares of the Company (representing 0.06 per cent. of the Company's current issued share capital) and holds 800,000 options over Ordinary Shares.

 

Image Scan's Chairman and Chief Executive, Bill Mawer, commented: "After three years of rapid growth in sales and profits, the cancelled order and the failure of the attempted acquisition have come as disappointments. A decline in portable X-ray orders has exacerbated this. While the instant increase in scale that the acquisition of Todd Research would have brought would have been welcome, our order pipeline is strong, and I am confident the changes to our team and the re-focus of our research and development efforts can return us to our previous growth path. I would like to welcome Sarah to her new, expanded role on the Board."

 

 

-ENDS-

 

For further information, please contact:

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

William Mawer, Chairman

Sarah Atwell-King, Company Secretary

ir@ish.co.uk

 

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000

Rick Thompson / Will Goode (Corporate Finance)

Caspar Shand Kydd (Sales)

 

About Image Scan Holdings plc

Image Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time X-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the ThreatScan® range of portable bomb and suspect package detection systems; the Axis range of baggage inspection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet X-ray systems for laboratories and production lines. The Company was founded in 1996 and joined AIM in 2002.

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQXLFLVBFLFBB
Date   Source Headline
5th Jun 20269:45 amRNSContract Award
30th Apr 20267:00 amRNSInterim Results
25th Feb 20262:27 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement
2nd Feb 20267:00 amRNSUpdate on Defence Contract with NP Aerospace
21st Jan 20261:31 pmRNSNotice of AGM and Posting of Annual Report
2nd Dec 20257:00 amRNSFinal Results
18th Nov 20257:00 amRNS-RContract Award
11th Nov 20257:00 amRNSNew Contract Award
4th Nov 20257:00 amRNSTrading Update
2nd Sep 202511:23 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTrading Update And New Contract Awards
20th May 20258:32 amRNSInterim Results
14th May 202511:55 amRNSHolding(s) in Company
26th Feb 20252:38 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Statement
15th Jan 202510:48 amRNSNotice of AGM & Posting of Annual Report
3rd Dec 20247:00 amRNSFinal Results
23rd Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSContract Award Update
4th Sep 20247:00 amRNSHolding(s) in Company
21st Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
4th Jul 20247:00 amRNSContract Award
12th Jun 20247:00 amRNSContract award worth over £350k
20th May 20244:33 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.